The Challenge
OTC Link LLC, a broker-dealer registered with the SEC since 2012, faced allegations of repeatedly failing to establish and enforce adequate compliance policies and procedures for OTC Link ATS, one of its five alternative trading systems handling over-the-counter stocks. The SEC's enforcement action resulted in a $575,000 settlement announced this week.
The word "repeatedly" in the SEC's order is significant. This wasn't a one-time oversight or a gap discovered during routine examination. The pattern suggests systemic weakness in how OTC Link approached compliance program design and maintenance for a platform facilitating real trades with real regulatory obligations.
The Environment and Constraints
OTC Link operates as an indirect wholly owned subsidiary of OTC Markets Group, running five separate alternative trading systems. This structure creates inherent compliance complexity. Each ATS has distinct operational characteristics, but all fall under the broker-dealer registration umbrella that's been in place since 2012.
Alternative trading systems occupy a specific regulatory space. Unlike traditional exchanges, ATSs match buyers and sellers outside public markets, but they're still subject to SEC oversight as broker-dealers. The compliance framework is mandatory. Regulation ATS under the Securities Exchange Act of 1934 establishes clear requirements for fair access, system capacity, integrity, and operational transparency.
For a firm operating multiple platforms, the compliance program must address each system's unique risks while maintaining enterprise-wide consistency. You can't assume that policies adequate for one ATS automatically cover another. Different trade volumes, participant types, and order handling mechanisms demand tailored controls.
The Approach Taken
The SEC's order indicates OTC Link's approach fell short on both design and enforcement. "Failed to create and enforce" points to two distinct failures: the policies either didn't exist in adequate form, or they existed but weren't consistently applied.
This dual failure pattern typically emerges from one of three root causes. First, the compliance function may have lacked sufficient resources or authority to build comprehensive policies. Second, business units may have operated with inadequate compliance oversight, treating policy requirements as suggestions rather than controls. Third, the firm may have failed to update its compliance framework as the platform evolved, leaving gaps between actual operations and documented procedures.
What's clear from the settlement is that whatever compliance structure existed, it didn't meet the SEC's expectations for a registered broker-dealer operating alternative trading systems. The "repeated" nature of the failures suggests the firm didn't self-identify and remediate the gaps through its own monitoring processes.
Results and Metrics
The settlement cost OTC Link $575,000. That's the direct financial impact, but it's not the full cost of compliance failure.
Consider what happens after a settlement like this. The SEC publishes the order. Clients and counterparties read it. Competitors reference it. Your compliance team spends months documenting remediation. External counsel reviews your entire compliance program. You might face increased examination frequency. Insurance premiums adjust. Recruiting experienced compliance talent becomes harder when candidates can Google your enforcement history.
The $575,000 represents the penalty the SEC deemed appropriate for the violations described in the order. It doesn't capture the operational disruption, the reputational cost, or the expense of building the compliance program you should have had in the first place.
What They Would Do Differently
While the settlement order doesn't detail OTC Link's remediation commitments, the nature of the violations points to clear corrective actions any broker-dealer would need to implement.
Start with a comprehensive policy gap analysis against Regulation ATS requirements. Document each compliance obligation, map it to existing policies and procedures, and identify gaps. Don't assume your policies are adequate because they've existed for years. Test them against current operations.
Build enforcement mechanisms into your compliance program design. Policies without monitoring are suggestions. You need regular testing of key controls, exception reporting that surfaces policy violations, and escalation procedures that bring gaps to senior management attention before they become patterns.
Separate compliance resources by business line when you operate multiple platforms. Shared compliance functions create efficiency, but they can also create blind spots. Each ATS needs dedicated compliance oversight that understands its specific operational risks.
Implement a formal Policy Gap Analysis cycle tied to operational changes. When you modify how your platform handles orders, your compliance policies must be updated in parallel. Too often, business units move faster than compliance documentation, creating gaps that examiners will find.
Takeaways for Your Team
If you're a compliance officer at a broker-dealer or any firm with SEC registration obligations, this settlement offers three immediate lessons.
First, "adequate" compliance policies are not static. What satisfied examiners three years ago may not meet current expectations. The SEC's examination priorities evolve. Your compliance program must evolve with them. Schedule annual reviews of your entire policy framework, not just the policies that seem problematic.
Second, enforcement matters as much as design. You can have the most comprehensive compliance manual in your industry, but if your business units don't follow it consistently, you have a compliance failure. Build monitoring into your program from day one. Test controls quarterly. Document exceptions. Escalate patterns.
Third, the cost of building a proper compliance program is always less than the cost of settling an enforcement action. The $575,000 OTC Link paid could have funded significant compliance infrastructure, staffing, and technology. Instead, it went to the SEC, and the firm still needs to build that infrastructure.
If you operate in a regulated space with multiple business lines or platforms, map your compliance obligations to your organizational structure now. Identify where policies might not cover current operations. Test whether your monitoring would catch the kinds of repeated failures the SEC found at OTC Link. Don't wait for an examination to discover gaps you could have closed yourself.
The settlement is public. The lessons are free. The question is whether you'll apply them before your next examination.
